The global nutraceutical
gummies market is projected to grow from USD 24.39 billion in 2025 to
USD 47.80 billion by 2030, registering a robust compound annual growth rate (CAGR) of 14.4% during the forecast period. The market is witnessing
substantial expansion due to shifting consumer health priorities and evolving
supplement consumption habits worldwide.
Increasing preference for
convenient, palatable, and easy-to-consume supplement formats is encouraging
consumers across all age groups to transition from traditional tablets and
capsules to gummy-based nutraceuticals. Growing awareness regarding preventive
healthcare, immune support, digestive wellness, and routine nutritional
supplementation is further accelerating demand for products containing
vitamins, minerals, probiotics, and other functional ingredients.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15848651
Asia Pacific Emerging as the
Fastest-Growing Regional Market
Asia Pacific is projected to
be the fastest-growing region in the nutraceutical gummies market during the
forecast period. The growth is primarily attributed to the high prevalence of
micronutrient deficiencies and the growing demand for child-friendly supplementation
formats. According to UNICEF, approximately one in two young children in East
Asia and the Pacific—around 52 million children under the age of five—suffers
from at least one micronutrient deficiency, highlighting a significant regional
nutrition gap.
This widespread deficiency
is driving demand for preventive nutrition solutions, where nutraceutical
gummies provide an effective, palatable, and easy-to-administer option,
particularly for children who resist traditional dosage forms such as tablets
or syrups. Beyond pediatric nutrition, the increasing micronutrient burden is
encouraging broader adoption of fortified supplements among adults,
strengthening B2C demand and prompting nutraceutical companies to expand
production of convenient dosage formats. Manufacturers and contract formulators
are increasingly focusing on the Asia Pacific region to address large unmet
nutritional requirements, positioning it as a key growth hub for the market.
Gen Alpha Emerging as the
Fastest-Growing Consumer Segment
The Gen Alpha demographic
segment (0–12 years) is expected to be the fastest-growing consumer group in
the nutraceutical gummies market. This growth is largely driven by the global
burden of childhood micronutrient deficiencies and increasing emphasis on early
preventive nutrition. Recommendations from global health organizations,
including the World Health Organization (WHO), highlight the importance of
adequate vitamin and mineral intake during childhood to support immunity,
growth, and cognitive development.
Gummy and chewable
supplement formulations significantly improve compliance among children due to
their appealing taste, texture, and ease of consumption. As parents
increasingly seek child-friendly nutritional solutions, nutraceutical gummies
are gaining rapid acceptance, positioning Gen Alpha as a key growth driver for
the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=15848651
Small-Scale Contract
Manufacturers Driving Innovation and Market Expansion
Small-scale contract
manufacturers with production capacities below 10 million units per year are
emerging as the fastest-growing manufacturing segment. Many emerging
nutraceutical brands lack the capital investment, specialized infrastructure,
and regulatory expertise required for in-house gummy production. Outsourcing to
flexible contract manufacturers enables these brands to scale production
efficiently, optimize cost structures, and meet quality compliance requirements
without significant capital expenditure.
These contract manufacturers
also support faster time-to-market for new product formulations while allowing
brands to focus on marketing, branding, and product differentiation. As the
nutraceutical industry continues to evolve with increasing demand for plant-based
ingredients, clean-label formulations, and customized dosage solutions, smaller
contract manufacturers are well-positioned to meet specialized production
requirements through technical expertise, regulatory support, and certified
manufacturing infrastructure.
Hydrocolloid-Based Gummy
Bases Gaining Traction
The agar, carrageenan, and
other hydrocolloids segment is emerging as one of the fastest-growing gummy
base segments in the nutraceutical gummies market. These plant-derived gelling
agents enable the production of vegan, halal/kosher-compliant, and clean-label
gummy formulations while delivering desirable texture, stability, and moisture
retention properties.
Agar offers strong and
thermally stable gels suitable for heat-sensitive active ingredients, while
carrageenan and related hydrocolloids provide precise control over chewiness,
elasticity, and ingredient release. These properties are critical for fortified
formulations and functional nutrition claims, making hydrocolloid-based gummy
bases increasingly popular among manufacturers.
Leading Nutraceutical
Gummies Companies:
The report profiles major
companies operating in the nutraceutical gummies market, including Church &
Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG
(Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co.,
Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM
Healthcare (India), SMP Nutra (US), Nature’s Truth (US), and Herbaland Naturals
Inc. (Canada).
Prominent contract
manufacturers profiled in the report include Sofgen Pharma (Luxembourg),
Catalent, Inc. (US), Activ'Inside (France), WinNutra (US), Makers Nutrition,
LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India),
Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US),
Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among others.
